Deploying the SEC‐ILM procedure, there were no significant differences in the vesiclemia values from HR+ MBC patients and age‐matched healthy women (Figure 2b), nor with other BC subtypes (i.e., HER2+ and TNBC) (Figure S2A). Here, ERBB2 is linked to breast cancer.